BioCentury
ARTICLE | Company News

Cel-Sci, ImmunoRx cancer news

February 12, 1996 8:00 AM UTC

CELI filed suit against ImmunoRx and John Hadden, alleging contract breach and patent infringement of CELI's Multikine immune system drug.

CELI alleged that ImmunoRx and Hadden are making copies of Multikine and have gone into clinical studies with their copy of Multikine. ...